Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Similar documents
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Trial Management: Trial Master Files and Investigator Site Files

Document Title: Study Data SOP (CRFs and Source Data)

Investigator Site File Standard Operating Procedure (SOP)

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Document Title: Investigator Site File. Document Number: 019

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

Standard Operating Procedure (SOP) Research and Development Office

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Document Title: Recruiting Process. Document Number: 011

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

STANDARD OPERATING PROCEDURE SOP 325

Document Title: GCP Training for Research Staff. Document Number: SOP 005

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

1. INTRODUCTION 2. SCOPE 3. PROCESS

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

managing or activities.

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Document Title: Version Control of Study Documents. Document Number: 023

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Good Clinical Practice: A Ground Level View

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

STH Researcher. Recording of research information in patient case notes

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

QUALITY ASSURANCE PROGRAM

Document Title: File Notes. Document Number: 024

GCP Training for Research Staff. Document Number: 005

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Training Records. Document Number: SOP 004

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Unofficial copy not valid

Document Title: Informed Consent for Research Studies

Document Title: Research Database Application (ReDA) Document Number: 043

Standard Operating Procedures (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

Document Title: Document Number:

STANDARD OPERATING PROCEDURE

Joint R&D Support Office SOP S-2011 UHL

Checklist prior to recruiting first patient

Auditing of Clinical Trials

Effective Date: 11/09 Policy Chronicle:

Monitoring Clinical Trials

VCU Clinical Research Quality Assurance Assessment

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

GCP INSPECTION CHECKLIST

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

Safety Reporting in Clinical Research Policy Final Version 4.0

Standard Operating Procedure Research Governance

Storage and Archiving of Research Documents SOP 6

COMPETENCY FRAMEWORK

Standard Operating Procedures

Standard Operating Procedure

Setting up a Clinical Trial

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

Research Staff Training

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Study Monitoring Plan Template

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

Keele Clinical Trials Unit

Standard Operating Procedures (SOP) Research and Development Office

The GCP Perspective on Study Monitoring

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

Standard Operating Procedure (SOP) Research and Development Office

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

FDA Medical Device Regulations vs. ISO 14155

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

STANDARD OPERATING PROCEDURE

BIMO SITE AUDIT CHECKLIST

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Good Documentation Practices. Human Subject Research. for

Referral for Imaging by Non-Medical Staff Policy

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

EMA Inspection Site perspective

A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off

Clinical Study Risk Assessment

Corporate. Research Governance Policy. Document Control Summary

Transcription:

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally Sponsored Studies ID Number 2011-153 Author s name F. Smith Author s job title R&D Manager, Chair R&D SOP Working Group Division Medical Executive Department Research and Development Version number 2.1 Ratifying Committee Research and Development Steering Group Ratified date Sept 2011 Review date Sept 2014 Name of manager responsible for review F. Smith Job title of manager responsible for review R&D Manager Email address for this manager Fiona.Smith@whht.nhs.uk Referenced (Yes/No) Yes Key words (to aid searching) Research, Responsibilities, External, Sponsor User Group All staff involved in research Equality Impact Assessment Completed Not required The Trust is committed to promoting an environment that values diversity. All staff are responsible for ensuring that all patients and their carers are treated equally and fairly and not discriminated against on the grounds of race, sex, disability, religion, age, sexual orientation or any other unjustifiable reason in the application of this policy, and recognising the need to work in partnership with and seek guidance from other agencies and services to ensure that special needs are met. 1 of 7

Change History Version Date Author Reason Ratification Required Version 1 Feb 2006 Fiona Smith Yes Version 2 Sept 2008 Fiona Smith Review Yes Version 2.1 Sept 2011 Fiona Smith Review Yes 1. BACKGROUND To ensure the smooth and accurate conduct of research studies appropriately qualified personnel are required. This may include staff directly involved in the conduct of the research such as: Principal Investigator Co-investigator Research practitioners (e.g. research nurses/practitioners/officers/co-ordinators) Study co-ordinators (e.g. data managers/research assistants) In addition there may be staff associated with, but not directly involved in the research trial including: Clinicians Specialist nurses Pharmacists Laboratory staff Other Support staff e.g. radiology For a trial to run safely it is essential that all staff involved are aware of the anticipated extent of their involvement and limits to their authority. ICH Good Clinical Practice Guidelines define an investigator as A person responsible for the conduct of the clinical trial at a trial site. The investigator is responsible for protecting the integrity, health and welfare of the trial subjects during the trial. The investigator must be: Qualified by education, training and experience and legally allowed to practice medicine Thoroughly familiar with the study protocol and the investigational product(s) Aware of, and compliant with Good Clinical Practice and any applicable regulatory requirements pertaining to clinical trial conduct If a team of investigators conducts a trial at a trial site the investigator responsible for leading the team is usually referred to as the Principal Investigator (PI). Other investigators are referred to as co-investigators or sub-investigators. The term investigator in this SOP refers to the PI and all co-investigators. 2 of 7

2. PURPOSE To assist in the division and allocation of responsibilities and to clarify boundaries of responsibility within the local study team, to ensure the smooth running of the trial. Will also where applicable provide the Sponsor with an overview of the division of responsibilities within the trial. 3. PROCEDURE During the pre-study phase, the Principal Investigator, co-investigator(s) if applicable and the assigned research practitioner responsible for the clinical trial must discuss and agree on the study requirements with the representative from the Sponsor company if appropriate. The delegation of tasks will depend on the qualifications and experience of the individuals in the team, and may vary from study to study. Individual trial related duties and functions should be defined, established and allocated prior to the initiation of a trial. Each trial will have a Principal Investigator, who has overall responsibility for: The welfare of patients The medical care of trial subjects Informed consent Conduct of the study in compliance with the protocol Administration and management storage of investigational product as appropriate Ensuring that local management needs are met Obtaining approval of and continued communication with regulatory bodies e.g. Ethics Committee and Trust management Safety reporting e.g. Adverse Events and Serious Adverse Events The accurate and timely completion of trial data Archiving The PI can nominate an appropriately experienced person, for example a Research Nurse or Clinical Trial Practitioner, to assist in the management of the trial at the investigational site. This person, along with the PI, where required, will discuss and agree the allocation of tasks with staff members. The allocation of tasks to appropriately qualified persons should be recorded on a Study Delegation Log (SDL)/Site Responsibility Log (SRL) with specimen signatures and initials of all involved. See Appendix A. The SDL/SRL will: List names of staff delegated to each procedure Be up to date Be signed and dated by the investigator, supplied to the Sponsor company if applicable and updated as required throughout the trial Be filed appropriately in the investigator site file. If archived by Sponsor, ensure copy remains at site Should be updated as new staff are recruited, but superseded versions must not be destroyed in order to provide an audit trail for future inspection 3 of 7

The external Sponsor should be made aware of the planned division of tasks. Contact names and roles of other individuals involved in the trial (e.g. Pharmacy, laboratory staff) should also be notified to the Sponsor. The PI, along with the research nurse/clinical trial practitioner/officer/co-ordinator should review the need for additional staff, and discuss changes with the Sponsor as appropriate on an ongoing basis. Some trial related responsibilities may be delegated to appropriately qualified personnel according to local practice, this will be documented on the SDL and signed and dated by the PI. Refer to the table in Appendix B re tasks commonly associated with Clinical research team roles. 4. OTHER RELATED PROCEDURES All other Research SOPs 5. REFERENCES ICH-GCP, Guidelines for Clinical Practice, http://ichgcp.net/ 6. APPENDICES Appendix A: Appendix B: Centre Delegation Log Approved Responsibilities of Site Staff Form 4 of 7

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust APPENDIX A. Study Title/Acronym: CENTRE DELEGATION LOG Protocol No: Principal Investigator: Study Site: Name Position* Usual Initials Signature Date of signature Date & Signature of PI * Each position is associated with particular trial responsibilities. These are described in the table in Appendix B; however, the titles should be adapted per local requirements. The list of trial related duties given here is not exhaustive; other trial specific functions should be documented. 5 of 7

APPENDIX B *APPROVED RESPONSIBILITIES OF SITE STAFF *This is not an exhaustive list and will require annotating at a local level to take into account local Network practices and policies. Position Co-investigators APPROVED RESPONBILITIES OF SITE STAFF Medical care of patients Screening of patients for eligibility Informed consent Sign consent form Randomisation Responsible for administration of study drug Responsible for collection of trial specific blood samples Completion and return of CRFs and providing responses to data queries Prescriptions Timely SAE reporting Ethics committee obligations Research Nurse/ Clinical Trial Practitioner Screening of patients Informed consent (according to local practice) Randomisation Completion and return of CRFs Data queries Documentation of adverse events in source data Investigator/Study file set up and management Support monitoring visits and audits and inspections Preparation of paperwork for Ethics committee/r&d Preparation of SAE reports for medical input and causality assessment 6 of 7

Data Manager Taking and shipping of trial related samples Notification to Scanner Centre and Medical Physics of studies involving investigations that require a radiation dose (eg bone scans, MUGA scans, CT scans). Provide request forms for these investigations which carry a sticker to show whether the investigation falls within standard practice or is purely a requirement of the clinical trial Data entry Completion and return of CRFs Data queries Support monitoring visits, audits and inspections (Research) Pharmacist Acknowledge receipt of trial supplies Drug accountability and monitoring of compliance Dispensing of Investigational Product to patients Complete dispensing logs Maintain Pharmacy file Monitor storage of Investigational Product PI Signature: Date: 7 of 7